Fewer Area Firms Get More Venture Capital

Washington area venture capital investments rose during the first quarter, though funding went to a smaller pool of more-seasoned companies in the biotechnology and software industries than a year ago.
 - 

Kim Hart

Related Subjects

Bruce Robertson

PricewaterhouseCoopers LLP

Intersouth Partners

MEDIMMUNE INC.

Paladin Capital Group

H.I.G. Ventures

AstraZeneca Group

Legend Ventures

Arxan Technologies Inc.

Amplifier Ventures

Bethesda

Rockville

Jonathan Aberman

McLean (Virginia)

Columbia (Maryland)

National Venture Capital Association

Washington, DC

Venture Capital

Private Equity

Business

Technology

Science and Technology

Biotechnology

Software

Computer Technology

Biotechnology Industry

Pharmaceuticals and Biotechnology Sector

Health and Human Services Sector

Pharmaceuticals Industry

Startups

Powered by Inform

Related Articles

MedImmune deal is seen as plus for Maryland's biotech industry Maryland Gazette 4/26/2007 11:36:59 PM

Flu Gene Database Speeds ID And Tracking Of Emerging Influenza Strains Science Daily 4/26/2007 10:48:22 PM

XOMA Announces May 10 Conference Call and Webcast Discussion of First Quarter 2007 Financial Results MSN Money 4/26/2007 8:42:31 PM

Welichem Filed Quarterly Report for Period Ended February 28, 2007 CCNMatthews 4/26/2007 7:54:01 PM

Gujarat aims to up area under oilseeds, foodgrain Business Standard 4/26/2007 5:42:33 PM

Increasing Ethanol Yields: Tiny Pores In Plant Cells Lead The Way Science Daily 4/26/2007 5:35:55 PM

Wyeth shareholders seek to recoup unearned manager bonuses Asbury Park Press 4/26/2007 5:35:20 PM

Time is running out for generic biotech Boston Globe 4/26/2007 5:27:19 PM

Business teams compete for $80K Pacific Business News 4/26/2007 5:11:00 PM

EU Lawmakers Back New Stem Cell Rules NewsMax 4/26/2007 1:59:02 PM

Related Blogs

Biotech financing: Not everyone gets a turn at the firehose VentureBeat 4/26/2007 1:52:17 PM

The Angel Is in the Details TCS Daily 4/25/2007 7:47:54 AM

The boulevard of broken IPO dreams VentureBeat 4/23/2007 11:57:26 PM

Cramer's bank and biotech picks Blogging Stocks 4/23/2007 3:59:34 PM

AstraZeneca ups the biotech ante VentureBeat 4/23/2007 1:56:23 PM

Powered by Inform